Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)

NCT04460001 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Ophthalmopathy

Interventions

DRUG: Ranibizumab
DRUG: Ranibizumab
DRUG: triamcinolone acetate

Sponsor

Assiut University